RLYB (Rallybio Corporation Common Stock) Stock Analysis - Analyst Ratings
Rallybio Corporation Common Stock (RLYB) is a publicly traded Healthcare sector company. As of May 21, 2026, RLYB trades at $14.43 with a market cap of $74.70M and a P/E ratio of -5.06. RLYB moved +2.18% today. Year to date, RLYB is +168.41%; over the trailing twelve months it is +427.04%. Its 52-week range spans $1.76 to $15.31. Rallies surfaces RLYB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate RLYB?
The average price target is $0.00.
RLYB Key Metrics
Key financial metrics for RLYB
Metric
Value
Price
$14.43
Market Cap
$74.70M
P/E Ratio
-5.06
EPS
$-2.84
Dividend Yield
0.00%
52-Week High
$15.31
52-Week Low
$1.76
Volume
86
Avg Volume
0
Revenue (TTM)
$858.00K
Net Income
$-7.82M
Gross Margin
0.00%
RLYB Analyst Consensus
RLYB analyst coverage data. Average price target: $0.00.